Effect of UGT Genetic Variation on Pharmacokinetics of Empagliflozine
Status:
Not yet recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The aim of this works is to investigate the effect of genetic polymorphism of snps on human
response to treatment with empagliflozine and its correlation with with pharmacokinetic
parameters in Egyptian subjects